Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications. (February 2018)

• Record Type: Journal Article
• Authors: Xiao, Xin; Garbutt, Cassandra C.; Hornicek, Francis; Guo, Zheng; Duan, Zhenfeng
• Is Part Of: Cancer treatment reviews. Volume 63(2018)
• Page Start: 61
• Page End: 70
• Publication Date: 2018-02
• Subjects: Chromosomal translocations -- Fusion genes -- Sarcomas -- Therapeutic strategies; Cancer -- Periodicals; Cancer -- Treatment -- Periodicals; Neoplasms -- therapy -- Periodicals; Cancer -- Périodiques; Cancer -- Traitement -- Périodiques; Cancer -- Treatment; Electronic journals; Periodicals; 616.99406
• DOI: 10.1016/j.ctrv.2017.12.001
• Languages: English
• ISSNs: 0305-7372

Abstract

Highlights: Chromosomal translocations and fusion genes are especially common in sarcomas. Novel chromosomal translocations and fusion genes have been discovered in sarcomas. Fusion genes and affected downstream signaling pathway provide therapeutic targets. Novel therapeutic targets show promise in future treatment of sarcomas. Abstract: Chromosomal translocations and fusion genes are very common in human cancer especially in subtypes of sarcomas, such as rhabdomyosarcoma, Ewing's sarcoma, synovial sarcoma and liposarcoma. The discovery of novel chromosomal translocations and fusion genes in different tumors are due to the advancement of next-generation sequencing (NGS) technologies such as whole genome sequencing. Recently, many novel chromosomal translocations and gene fusions have been identified in different types of sarcoma through NGS approaches. In addition to previously known sarcoma fusion genes, these novel specific fusion genes and associated molecular events represent important targets for novel therapeutic approaches in the treatment of sarcomas. This review focuses on recent advances in chromosomal translocations and fusion genes in sarcomas and their potential therapeutic applications in the treatment of sarcomas.